ADL BioPharma closes 2021 with a turnover increase of more than 60%
ADL BioPharma had a turnover of nearly 38 million euros, thus increasing its sales by almost 14.5 million euros compared to 2020, and was able to sign long-term customer contracts. ADL BioPharma closed 2021 with a turnover of 38 million euros, which is almost 14.5...
ADL BioPharma and the Halal Institute sign a pioneering collaboration agreement in the biotechnology sector
The Halal Institute, with offices in Cordoba, Lisbon and Mexico City, will offer certification services for all the processes and products produced at ADL BioPharma facilities, while the Leon-based company will promote the application of the Islamic Board’s Halal...
ADL BioPharma renews its corporate image and consolidates itself as a strategic partner in Europe to accelerate and optimize biotechnology projects
In this new stage they are committed to innovation, resource optimization and the product quality from economic and environmental sustainability. The biopharmaceutical Company ADL BioPharma, with more than 60 years of experience in the biopharmaceutical sector, renews...
